Industry News

Catalent to Acquire Metrics Contract Services for $475 Million

August 10, 2022

Catalent will acquire Metrics Contract Services for $475 million to expand high-potent capabilities and oral development and manufacturing capacity.

FDA Approves Coherus’ Interchangeable Biosimilar for Lucentis

August 10, 2022

FDA has approved Coherus’ Cimerli (ranibizumab-eqrn) as an interchangeable biosimilar for all five indications of Lucentis.

Sanofi and Innovent Enter Oncology Collaboration

August 10, 2022

Sanofi and Innovent have entered into a strategic collaboration to accelerate development of oncology medicines and expand their presence in China.

Senate Advances Drug Price Negotiations

August 10, 2022

Democrats approve curbs for Medicare plans, but not for commercial drug coverage.

La Jolla Institute for Immunology Acquires Carterra LSA Platform

August 05, 2022

La Jolla’s acquisition of Carterra’s LSA Platform is designed to advance their immunological and infectious disease research.

Top Priority for Califf Is Combatting Health Misinformation

August 04, 2022

Better clinical data are needed, as well as strategies for tackling opioid abuse, tobacco use, and food safety.

CRYOPDP Acquires Polar Expres

August 02, 2022

CRYOPDP is expanding its footprint to Spain with its acquisition of Polar Expres.

Novasep-PharmaZell Invests €7.3M to Increase API Production Capacity

August 02, 2022

Novasep-PharmaZell will increase API production capacity at its Mourenx site with €7.3M investment.

New Guidance on the Use of Real-World Evidence

August 02, 2022

Pharma’s leveraging real-world evidence to drive product approval, reimbursement, and market access.

FDA Confirms Ongoing Reliance on Remote Inspection Methods

August 02, 2022

FDA’s hybrid inspection model will remain a regular means for supplementing onsite inspections and will be further integrated into the agency’s oversight operations.